Skip to main content

EFFECTIVE MONDAY, OCTOBER 21, Patients visiting 170 Maple Avenue will enter from Maple Avenue and exit onto Davis Avenue. Please be aware of this new traffic pattern.

Joshua Raff, MD

About Ratings and Reviews

The star rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.

Gender Male
Languages English
Board certification

Medical Oncology, Hematology

Medical school Tel-Aviv University
Residency Montefiore Medical Center
Fellowship Montefiore Medical Center
Specialty

Gastrointestinal Cancer, Lung Cancer, Prostate Cancer, Hemolytic Anemia, Platelet Disorders

Group White Plains Hospital Physician Associates
Accepted insurance View accepted health insurance plans

About

Joshua Raff, M.D. is the Director of the Digestive Cancer Program at White Plains Hospital, as well as the Leader of the Hospital's GI Cancer Program Conference. Dr. Raff received his medical degree from the Sackler School of Medicine at Tel Aviv University in 1997. He completed his residency in internal medicine at Montefiore Medical Center in the Bronx, and was a fellow of hematology and oncology at Albert Einstein College of Medicine from 2000-2003.

Dr. Raff is board certified in Hematology, and Medical Oncology. His professional experience and interests include: Cancers of the digestive system, lung cancer, prostate cancer; anemia, platelet disorders, and lymphoma. Dr Raff is actively involved in clinical research, and is the Principal Investigator for several therapeutic clinical trials at WPH.

In the news

Article

Power Over Pancreatic Cancer

The Hospital’s Pancreatic Cancer Screening Program offers life-saving early detection for those at risk of pancreatic cancer.

Article

A Potential Way of Catching Pancreatic Cancer Early

As with most medical conditions, early detection can be key to treatment. But roughly 80% of all diagnosed patients present at an advanced age and are ineligible for surgery.

Article

Immunotherapy Trials Offering Rays of Hope for Rectal, Lung Cancer Patients

While recent news is very encouraging, it is still too early to declare victory.

Article

3 Biggest Advances in Colorectal Cancer

Medical discoveries are offering hope against the third leading cause of cancer-related death.

Article

Early Detection Is Key to Stopping Pancreatic Cancer

The recent death of popular game show host Alex Trebek has focused attention on pancreatic cancer.

Podcast

Stopping Pancreatic Cancer in Its Tracks

Dr. Joshua Raff, Director of the Digestive Cancer Program at WPH, invites the public to take part in a screening program to identify pancreatic cancer risk in families.

Article

Top Surgeon’s Group Awards White Plains Hospital with Colorectal Cancer Honors

For colorectal cancer patients, the National Accreditation Program for Rectal Cancer means the most customized and specialized care plan possible.

Featured Video